Axion BioSystems
PrivateLast Round
Buyout/LBO
Jul 16, 2021
Total Funding Raised
$25,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Axion BioSystems is a life science tools company that develops and markets microelectrode array (MEA) and impedance-based systems for non-invasive, real-time study of cells for academic and biopharma customers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axion BioSystems Comparables
Compare Axion BioSystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 3Brain AG | 82% | |
| Sophion Bioscience | 81% | |
| MaxWell Biosystems | 81% |
Axion BioSystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Jul 16, 2021 | ||||
| VC Round | May 16, 2016 | ||||
| VC Round | Apr 1, 2012 | ||||
| Grant | Jun 1, 2007 |
Key People
Founding team and executive leadership
Axion BioSystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgia Research Alliance | Grant, VC Round |
| Summa Equity | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 39, 7.8x the trailing average.
- Jul 13, 2026
Open roles increased from 0 to 15, representing 12% of headcount.
Axion BioSystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access